MARKET

AORT

AORT

Artivion, Inc.
NYSE
29.14
+0.73
+2.57%
After Hours: 29.14 0 0.00% 19:34 08/14 EDT
OPEN
28.84
PREV CLOSE
28.41
HIGH
29.24
LOW
28.27
VOLUME
837.92K
TURNOVER
--
52 WEEK HIGH
48.25
52 WEEK LOW
19.16
MARKET CAP
1.42B
P/E (TTM)
-425.4015
1D
5D
1M
3M
1Y
5Y
1D
Artivion (AORT) Q2 2026 Earnings Call Transcript
The Motley Fool · 1d ago
Canaccord Genuity Sticks to Its Buy Rating for Artivion (AORT)
TipRanks · 1d ago
Artivion (AORT) Is Up 5.5% After FDA AMDS Approval And Reaffirmed 2026 Revenue Guidance - What's Changed
Simply Wall St · 2d ago
Artivion (AORT) Revenue Rose As Losses Emerged, Is It Still 37% Below Fair Value?
Simply Wall St · 4d ago
Weekly Report: what happened at AORT last week (0803-0807)?
Weekly Report · 4d ago
Alger Dynamic Opportunities Fund Q2 2026 Portfolio Update
Seeking Alpha · 5d ago
Artivion (AORT) Stock Can Revenue Growth Outrun Fresh Losses?
Simply Wall St · 6d ago
Oppenheimer Sticks to Their Buy Rating for Artivion (AORT)
TipRanks · 08/07 12:37
More
About AORT
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.

Webull offers Artivion Inc stock information, including NYSE: AORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AORT stock methods without spending real money on the virtual paper trading platform.